简介：
Overview
This study presents a non-invasive method for the transplantation of induced pluripotent stem cell-derived human microglia (iPSMG) into the brain of immunocompetent mice via a transnasal route. The protocol leverages cytokine administration and the deletion of endogenous microglia to enable effective integration of iPSMG, potentially paving the way for therapeutic approaches in neurodegenerative diseases.
Key Study Components
Area of Science
- Neuroscience
- Stem Cell Research
- Microglial Biology
Background
- Induced pluripotent stem cells can be differentiated into functional microglia.
- Microglial dysfunction is implicated in various neurodegenerative diseases.
- Transnasal delivery presents a novel approach to cell transplantation.
- Administering cytokines is crucial for cell viability post-transplantation.
Purpose of Study
- To develop a method for non-invasive microglial transplantation.
- To assess the feasibility of transnasal delivery in maintaining normal brain function.
- To evaluate the potential of iPSMG in replacing dysfunctional microglia.
Methods Used
- The primary platform involves transnasal transplantation of iPSMG in immunocompetent mice.
- Male mice were pre-treated with CSF1 receptor antagonist PLX5622 and a hyaluronidase solution to enhance nasal permeability.
- Cell suspensions were administered in multiple doses over specified timelines to ensure proper integration.
- Post-transplant monitoring involved assessing the presence and viability of transplanted cells.
Main Results
- Transplanted iPSMG were successfully integrated into the mouse hippocampus without damaging endogenous microglia.
- Cytokine administration every 12 hours was critical for maintaining cell viability after transplantation.
- This method allows the examination of iPSMG responses in both normal and diseased models.
Conclusions
- This protocol facilitates the study of iPSMG in vivo, which could inform future gene therapies for neurodegenerative diseases.
- Understanding the behavior of transplanted microglia can help delineate their role in brain health.
- This approach may open avenues for novel therapeutic targets in treating microglial-related pathologies.
What are the advantages of transnasal transplantation?
Transnasal transplantation is a non-invasive approach that minimizes brain damage and allows for direct delivery of cells into the brain.
How is the microglial cell model prepared?
Microglial cells are prepared from induced pluripotent stem cells, thawed, and cultured before transplantation.
What types of outcomes can be measured post-transplantation?
Outcomes include the integration of iPSMG into the brain tissue and their functional viability, assessed through specific marker detection.
Can this method be adapted for other types of cells?
While primarily designed for iPSMG, the transnasal delivery method may potentially be adapted for other cell types, pending compatibility.
What are the limitations of this protocol?
Limitations include the requirement for careful preparation of cells and the need for continuous cytokine administration to ensure cell viability.
繁體中文
